Deferasirox Tablet, Film Coated
Product Images NDC 46708-410

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 46708-410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Deferasirox 180

Label for Deferasirox Tablets 180 mg, film-coated oral tablets supplied in a 30-tablet package. Manufactured by Alembic Pharmaceuticals Limited, the label includes storage instructions, dosage note to see package insert, dispensing guidance for pharmacists, and manufacturer location in Gujarat, India. The National Drug Code (NDC) is 46708-411-30.*

FDA Label Image

Deferasirox 360

Deferasirox Tablets 360 mg film-coated tablets label by Alembic Pharmaceuticals Limited. The label includes storage instructions, dosage advisory, and manufacturing details. It shows a package size of 30 tablets with prescription only status and a barcode with an NDC number 46708-412-30.*

FDA Label Image

Deferasirox 90

Deferasirox Tablets 90 mg film-coated oral tablets label. The label includes dosage strength, storage instructions, manufacturer Alembic Pharmaceuticals Limited, and a barcode. Packaging is primarily white with purple accents and contains 30 tablets.*

FDA Label Image

Figure 1 (Deferasirox Figure1)

A bar chart depicting the change in liver iron content (mg Fe/g dry weight) and serum ferritin (mcg/L) across different deferasirox doses (5, 10, 20, and 30 mg/kg/day). The chart compares the decreases and increases in these parameters with sample sizes indicated for each dose group.*

FDA Label Image

Structure (Deferasirox Structure)

Chemical structure diagram of Deferasirox, showing its molecular framework with several phenyl rings and hydroxyl groups, consistent with the active ingredient Deferasirox in the provided drug information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.